Presenilin 1, presenilin 2, and the amyloid precursor protein (APP) were found to have a significant impact on early-onset AD, while the APOE-ε4 allele was a genetic risk factor for late-onset AD [2]. This evidence concerns the gene PSEN1 and Alzheimer disease.